🇺🇸 FDA
Company

Aquestive

Aquestive Therapeutics

AQST pharma USA

Quick answer

Aquestive is a pharma company (AQST) headquartered in WARREN, NJ, USA with 9 tracked pipeline programs.

Pipeline (9)

project

Diazepam Buccal Soluble Film 5, 7.5,10, 12.5,15 or 17.5 mg with individual dose determined according to age and weight category

Epilepsy

Phase 3 · small_molecule · completed

1 trials project

DESF

Allergic Reaction

Phase 2 · small_molecule · completed

1 trials project

Diazepam Buccal Film

Epilepsy

Phase 2 · small_molecule · completed

2 trials project

Diazepam Buccal Film 12.5 mg

Epilepsy

Phase 2 · small_molecule · completed

1 trials project

Ondansetron (ODFS)

Nausea and Vomiting, Postoperative

Phase 2 · small_molecule · completed

1 trials project

Riluzole Oral Soluble Film

ALS

Phase 2 · small_molecule · terminated

1 trials project

Riluzole Oral Soluble film (ROSF) 50 mg

Amyotrophic Lateral Sclerosis

Phase 2 · small_molecule · terminated

1 trials project

Ondansetron (ODFS)

Healthy

Phase 1 · small_molecule · completed

1 trials project

Ondansetron 8 mg ODFS without water

Healthy Participants

Phase 1 · small_molecule · completed

1 trials

Drugs (1)

drug

riluzole

RILUZOLE

Patents (8)

patent

US 12427121

Enhanced delivery epinephrine compositions

Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12403090

Oral film compositions and dosage forms having precise active dissolution profil

Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12290597

Oral film compositions and dosage forms having precise active dissolution profil

Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12023309

Enhanced delivery epinephrine compositions

Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11541002

Oral film compositions and dosage forms having precise active dissolution profil

Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11273131

Pharmaceutical compositions with enhanced permeation

Expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11191737

Enhanced delivery epinephrine compositions

Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11129799

Dual lane coating

Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)